Home
/
Emergent BioSolutions Inc.
/
Financials
/
Quarterly
Emergent BioSolutions Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Emergent BioSolutions Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$293.80M
Nov 7, 2024
Q2
2024
Jun 30, 2024
$254.70M
Aug 7, 2024
Q1
2024
Mar 31, 2024
$300.40M
May 2, 2024
Q3
2024
Sep 30, 2023
$270.50M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$337.90M
Aug 7, 2024
Q3
2023
Jun 30, 2023
$337.90M
Dec 11, 2023
Q3
2023
Mar 31, 2023
$164.30M
Dec 11, 2023
Q1
2024
Mar 31, 2023
$164.30M
May 2, 2024
Q3
2023
Sep 30, 2022
$239.90M
Dec 11, 2023
Q2
2023
Jun 30, 2022
$242.70M
Aug 9, 2023
Q3
2023
Jun 30, 2022
$242.60M
Dec 11, 2023
Q3
2023
Mar 31, 2022
$304.80M
Dec 11, 2023
Q1
2023
Mar 31, 2022
$307.50M
May 10, 2023
Q3
2022
Sep 30, 2021
$329.00M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$397.50M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$343.00M
Apr 29, 2022
Q3
2021
Sep 30, 2020
$385.20M
Nov 5, 2021
Q1
2016
Mar 31, 2016
$111.00M
May 6, 2016
Q3
2015
Sep 30, 2015
$164.94M
Nov 6, 2015
Q2
2015
Jun 30, 2015
$126.11M
Aug 6, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$231.10M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$140.90M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$222.20M
May 8, 2025
Q3
2025
Sep 30, 2024
$293.80M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$254.70M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$300.40M
May 8, 2025
Q2
2021
Jun 30, 2021
$397.50M
Jul 30, 2021
Q1
2021
Mar 31, 2021
$343.00M
Apr 30, 2021
Q3
2020
Sep 30, 2020
$385.20M
Nov 6, 2020
Q2
2021
Jun 30, 2020
$394.70M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$192.50M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$311.80M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$243.20M
Jul 31, 2020
Q1
2020
Mar 31, 2019
$190.60M
May 1, 2020
Q1
2019
Dec 31, 2018
$117.80M
May 8, 2019
Q3
2019
Sep 30, 2018
$173.60M
Nov 7, 2019
Q2
2019
Jun 30, 2018
$220.20M
Aug 2, 2019
Q1
2019
Mar 31, 2018
$117.80M
May 8, 2019
Q3
2018
Sep 30, 2017
$149.43M
Nov 2, 2018
Q2
2018
Jun 30, 2017
$100.77M
Aug 3, 2018
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$117.81M
May 4, 2018
Q3
2017
Sep 30, 2017
$149.43M
Nov 3, 2017
Q2
2017
Jun 30, 2017
$100.77M
Aug 4, 2017
Q1
2018
Mar 31, 2017
$116.86M
May 4, 2018
Q3
2017
Sep 30, 2016
$142.91M
Nov 3, 2017
Q2
2017
Jun 30, 2016
$91.24M
Aug 4, 2017
Q1
2017
Mar 31, 2016
$102.96M
May 5, 2017
Q3
2016
Sep 30, 2015
$158.38M
Nov 9, 2016
Q2
2016
Jun 30, 2015
$126.11M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$63.63M
May 6, 2016
Q3
2015
Sep 30, 2014
$137.95M
Nov 6, 2015
Q2
2015
Jun 30, 2014
$110.33M
Aug 6, 2015
Q1
2015
Mar 31, 2014
$53.88M
May 8, 2015
Q3
2014
Sep 30, 2013
$89.10M
Nov 10, 2014
Q2
2014
Jun 30, 2013
$82.44M
Aug 8, 2014
Q1
2014
Mar 31, 2013
$43.10M
May 12, 2014
Q3
2013
Sep 30, 2012
$66.59M
Nov 8, 2013
Q2
2013
Jun 30, 2012
$70.38M
Aug 6, 2013
Q1
2013
Mar 31, 2012
$50.31M
May 3, 2013
Q3
2012
Sep 30, 2011
$58.76M
Nov 1, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$51.20M
Oct 30, 2025
Q2
2025
Jun 30, 2025
($12.00M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($12.00M)
Oct 30, 2025
Q1
2025
Mar 31, 2025
$68.00M
May 8, 2025
Q3
2025
Mar 31, 2025
$68.00M
Oct 30, 2025
Q2
2025
Mar 31, 2025
$68.00M
Aug 7, 2025
Q3
2025
Sep 30, 2024
$114.80M
Oct 30, 2025
Q2
2025
Jun 30, 2024
($283.10M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($283.10M)
Oct 30, 2025
Q3
2025
Mar 31, 2024
$9.00M
Oct 30, 2025
Q1
2025
Mar 31, 2024
$9.00M
May 8, 2025
Q2
2025
Mar 31, 2024
$9.00M
Aug 7, 2025
Q3
2024
Sep 30, 2023
($263.40M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($261.40M)
Aug 7, 2024
Q3
2024
Jun 30, 2023
($261.40M)
Nov 7, 2024
Q3
2024
Mar 31, 2023
($186.20M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($186.20M)
May 2, 2024
Q2
2024
Mar 31, 2023
($186.20M)
Aug 7, 2024
Q3
2023
Sep 30, 2022
($87.10M)
Dec 11, 2023
Q2
2023
Jun 30, 2022
($56.40M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$76.50M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$1.60M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$49.90M
May 8, 2025
Q3
2025
Sep 30, 2024
$64.50M
Oct 30, 2025
Q2
2025
Jun 30, 2024
($203.50M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
$39.80M
May 8, 2025
Q3
2024
Sep 30, 2023
($242.10M)
Nov 7, 2024
Q3
2023
Jun 30, 2023
($292.90M)
Dec 11, 2023
Q2
2024
Jun 30, 2023
($292.90M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($147.60M)
May 2, 2024
Q3
2023
Mar 31, 2023
($147.60M)
Dec 11, 2023
Q3
2023
Sep 30, 2022
($45.30M)
Dec 11, 2023
Q3
2023
Jun 30, 2022
($76.30M)
Dec 11, 2023
Q2
2023
Jun 30, 2022
($72.00M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
$6.40M
May 10, 2023
Q3
2023
Mar 31, 2022
$6.90M
Dec 11, 2023
Q3
2022
Sep 30, 2021
($34.70M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
$14.50M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$95.40M
Apr 29, 2022
Q3
2021
Sep 30, 2020
$61.30M
Nov 5, 2021